Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BMS-986458 Alone and in Combination for Relapsed/Refractory Non-Hodgkin Lymphoma
NCT06090539Phase 2Recruiting
- Sponsor
- Bristol Myers Squibb
- Start
- Dec 2023
- Primary completion
- Oct 2027
- Countries
- 15
01
Overview
A Phase 2 trial of bms-986458 in non-Hodgkin lymphoma (NHL), sponsored by Bristol Myers Squibb. Started Dec 2023; status: recruiting.
02
Drugs
bms-986458
03
Conditions
non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT06090539.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06090539.